报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 2.91% | 8.99% | -46.7% | 25/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
2024-12-31 | 5.46% | -23.31% | 20.53% | 33/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
2024-09-30 | 4.53% | -34.16% | 69.66% | 38/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
2024-06-30 | 2.67% | -35.35% | 0% | 40/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
2024-03-31 | 2.67% | -23.28% | -62.5% | 30/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
2023-12-31 | 7.12% | -42.72% | 3.49% | 34/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
2023-09-30 | 6.88% | -34.72% | 66.59% | 38/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
2023-06-30 | 4.13% | -38.63% | 18.68% | 39/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
2023-03-31 | 3.48% | -29.41% | -72% | 28/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
2022-12-31 | 12.43% | -5.76% | 17.93% | 19/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
2022-09-30 | 10.54% | -0.75% | 56.61% | 16/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
2022-06-30 | 6.73% | 2.59% | 36.51% | 16/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
2022-03-31 | 4.93% | 6.94% | -62.62% | 10/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
2021-12-31 | 13.19% | 17.77% | 24.2% | 14/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
2021-09-30 | 10.62% | 13.7% | 61.89% | 18/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
2021-06-30 | 6.56% | 28.88% | 42.3% | 18/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
2021-03-31 | 4.61% | 37.2% | -58.84% | 9/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
2020-12-31 | 11.2% | -4.03% | 19.91% | 17/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
2020-09-30 | 9.34% | 3.43% | 83.5% | 24/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
2020-06-30 | 5.09% | -4.32% | 51.49% | 21/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
2020-03-31 | 3.36% | -20.57% | -71.21% | 13/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
2019-12-31 | 11.67% | 4.48% | 29.24% | 22/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
2019-09-30 | 9.03% | -1.74% | 69.74% | 22/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
2019-06-30 | 5.32% | -4.83% | 25.77% | 27/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
2019-03-31 | 4.23% | -7.24% | -62.13% | 11/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
2018-12-31 | 11.17% | -25.13% | 21.55% | 27/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
2018-09-30 | 9.19% | -18.31% | 64.4% | 23/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
2018-06-30 | 5.59% | -24.97% | 22.59% | 28/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
2018-03-31 | 4.56% | -10.59% | -69.44% | 7/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
2017-12-31 | 14.92% | -37.26% | 32.62% | 16/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
2017-09-30 | 11.25% | -43.89% | 51.01% | 17/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
2017-06-30 | 7.45% | -54.96% | 46.08% | 17/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
2017-03-31 | 5.1% | -57.85% | -78.55% | 5/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
2016-12-31 | 23.78% | -46.14% | 18.6% | 4/70 | 10% | 济川药业 | 14.64% | 行业排名> |
2016-09-30 | 20.05% | 2% | 21.22% | 3/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
2016-06-30 | 16.54% | 2% | 36.69% | 1/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
2016-03-31 | 12.1% | 2% | -72.59% | 2/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
2015-12-31 | 44.15% | -5.88% | -5.88% | 2/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |